These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30335082)

  • 21. Mixed dementia--the most common cause of dementia.
    Korczyn AD
    Ann N Y Acad Sci; 2002 Nov; 977():129-34. PubMed ID: 12480742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed dementia: Neglected clinical entity or nosographic artifice?
    Fierini F
    J Neurol Sci; 2020 Mar; 410():116662. PubMed ID: 31911281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
    Gold G; Giannakopoulos P; Herrmann FR; Bouras C; Kövari E
    Brain; 2007 Nov; 130(Pt 11):2830-6. PubMed ID: 17878206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.
    Corriveau RA; Bosetti F; Emr M; Gladman JT; Koenig JI; Moy CS; Pahigiannis K; Waddy SP; Koroshetz W
    Cell Mol Neurobiol; 2016 Mar; 36(2):281-8. PubMed ID: 27095366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive impact of subcortical vascular and Alzheimer's disease pathology.
    Chui HC; Zarow C; Mack WJ; Ellis WG; Zheng L; Jagust WJ; Mungas D; Reed BR; Kramer JH; Decarli CC; Weiner MW; Vinters HV
    Ann Neurol; 2006 Dec; 60(6):677-87. PubMed ID: 17192928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
    Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
    Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.
    Toledo JB; Arnold SE; Raible K; Brettschneider J; Xie SX; Grossman M; Monsell SE; Kukull WA; Trojanowski JQ
    Brain; 2013 Sep; 136(Pt 9):2697-706. PubMed ID: 23842566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular factors in dementia: an overview.
    Decarli C
    J Neurol Sci; 2004 Nov; 226(1-2):19-23. PubMed ID: 15537513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-mortem assessment in vascular dementia: advances and aspirations.
    McAleese KE; Alafuzoff I; Charidimou A; De Reuck J; Grinberg LT; Hainsworth AH; Hortobagyi T; Ince P; Jellinger K; Gao J; Kalaria RN; Kovacs GG; Kövari E; Love S; Popovic M; Skrobot O; Taipa R; Thal DR; Werring D; Wharton SB; Attems J
    BMC Med; 2016 Aug; 14(1):129. PubMed ID: 27600683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
    de la Torre JC
    Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening.
    Davey DA
    Neurodegener Dis Manag; 2014; 4(3):253-9. PubMed ID: 25095819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular cognitive impairment.
    Farooq MU; Gorelick PB
    Curr Atheroscler Rep; 2013 Jun; 15(6):330. PubMed ID: 23612956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.
    Erkinjuntti T
    Int J Clin Pract Suppl; 2001 May; (120):14-23. PubMed ID: 11406922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular dementias].
    Diehl J; Kurz A
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):145-54. PubMed ID: 11880947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of hippocampal volume measured using magnetic resonance imaging in Alzheimer's disease, vascular dementia, mild cognitive impairment and pseudodementia.
    Dolek N; Saylisoy S; Ozbabalik D; Adapinar B
    J Int Med Res; 2012; 40(2):717-25. PubMed ID: 22613435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General measures of cognition.
    Ferris SH
    Int Psychogeriatr; 2003; 15 Suppl 1():215-7. PubMed ID: 16191243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuropsychological features of mixed Alzheimer's and vascular dementia].
    Roshchina IF; Mikhaĭlova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10):11-7. PubMed ID: 24300799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.